HepaTx and Mayo Clinic Collaborate to Accelerate Cell Therapy for Liver Disease to Clinical Trials
HepaTx, a biotechnology company focused on regenerative medicine, has announced an exciting collaboration with the Mayo Clinic to advance its innovative cell therapy technology into clinical trials. This partnership, revealed on September 10, 2024, aims to offer new therapeutic approaches for liver diseases, initially targeting alcohol-related hepatitis. The collaboration leverages Mayo Clinic’s clinical research infrastructure […]
Stem Cell Therapy for Liver Disease: A New Horizon in Medical Treatment
Ever wondered if there’s a magic bullet for liver disease? While magic might be off the table, the realm of modern medicine brings us something almost as spellbinding: stem cell therapy. This cutting-edge treatment option is emerging as a beacon of hope for those battling the relentless waves of liver conditions. But before we dive into […]